This study is for patients who brain metastasis. Patients must have an actionable alteration in NTRK, ROS1, KRAS G12C or CDK pathway or P13K.
Contact phone
Tracy Bellefeuil | (517) 364-2835
Contact email
[email protected]
Principal investigator
Dr. Srkalovic, MD, PhD
Trial Category
Cancer
Trial SubCategory
Brain Mets
Webform